Bio Techne | TECH - Cash And Equivalent

Stock Price
43.30
Daily Change
-1.44 -3.22%
Monthly
-24.51%
Yearly
-11.90%
Q2 Forecast
42.43

Bio Techne reported $209.82M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Agilent USD 1.76B 31M Dec/2025
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Bio Techne USD 209.82M 36.94M Mar/2026
Bio-Rad Laboratories USD 507.2M 22.6M Mar/2026
Bruker USD 133.4M 165.4M Mar/2026
Charles River Laboratories USD 191.83M 21.94M Mar/2026
Danaher USD 5.7B 1.09B Mar/2026
Illumina USD 1.42B 368M Dec/2025
IQVIA Holdings USD 1.95B 33M Mar/2026
Merck EUR 2.33B 77M Dec/2025
Mettler Toledo International USD 66.89M 2.18M Dec/2025
OraSure Technologies USD 176.96M 22.31M Mar/2026
Pacific Biosciences Of California USD 56.27M 223.23M Mar/2026
Repligen USD 582.65M 16.63M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Standard Biotools USD 265.77M 147.56M Mar/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Waters USD 462M 125.83M Mar/2026